The effect of a low-calorie diet with and without fenfluramine on the glucose tolerance and insulin secretion of obese maturity-onset diabetics
- PMID: 4804456
- PMCID: PMC2495858
- DOI: 10.1136/pgmj.49.571.318
The effect of a low-calorie diet with and without fenfluramine on the glucose tolerance and insulin secretion of obese maturity-onset diabetics
Abstract
Glucose tolerance and insulin secretion have been measured in twenty-three obese maturity-onset diabetics (twelve high-insulin secretors and eleven lowor normal-insulin secretors) on first presentation and after 10 weeks on a low-calorie diet. There was a significant improvement in glucose tolerance alone, when the results were compared with those from diabetics not on any form of treatment.
Thereafter nine of these subjects (five high-insulin secretors and four low- or normal-insulin secretors) continued on the dietary therapy alone, and eleven of the remaining fourteen subjects (six high-insulin secretors and five low- or normal-insulin secretors) continued on the low-calorie diet with the addition of fenfluramine, and their glucose tolerance and insulin secretion were measured again after a further 10 weeks. The remaining three subjects were no longer studied. The nine subjects continuing on the diet alone showed maintenance of the improvement in glucose tolerance achieved during the first 10-week period with no significant change in insulin secretion. The eleven subjects placed on fenfluramine in addition to the diet also showed maintenance of the improvement in glucose tolerance achieved during the first 10-week period with a significant decrease in insulin secretion in the six high-insulin secreting subjects and no significant change in insulin secretion in the five lowor normal-secretors.
Similar articles
-
The effect of a low-calorie diet with and without fenfluramine, and fenfluramine alone on the glucose tolerance and insulin secretion of overweight non-diabetics.Postgrad Med J. 1973 May;49(571):314-7. doi: 10.1136/pgmj.49.571.314. Postgrad Med J. 1973. PMID: 4804455 Free PMC article. Clinical Trial.
-
Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.Drugs. 1975;10(4):241-323. doi: 10.2165/00003495-197510040-00001. Drugs. 1975. PMID: 765100 Review.
-
The effect of fenfluramine on obese, maturity-onset diabetic patients.Acta Endocrinol (Copenh). 1979 Apr;90(4):616-23. doi: 10.1530/acta.0.0900616. Acta Endocrinol (Copenh). 1979. PMID: 373358 Clinical Trial.
-
[Effects of ponderal on the state of carbohydrate metabolism and insulin secretion in type 2 diabetes mellitus].Sov Med. 1991;(11):56-9. Sov Med. 1991. PMID: 1767320 Russian. No abstract available.
-
[Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].Journ Annu Diabetol Hotel Dieu. 1972;13(0):55-65. Journ Annu Diabetol Hotel Dieu. 1972. PMID: 4605752 Review. French. No abstract available.
Cited by
-
The effect of a low-calorie diet with and without fenfluramine, and fenfluramine alone on the glucose tolerance and insulin secretion of overweight non-diabetics.Postgrad Med J. 1973 May;49(571):314-7. doi: 10.1136/pgmj.49.571.314. Postgrad Med J. 1973. PMID: 4804455 Free PMC article. Clinical Trial.
-
Metabolic effects of fenfluramine in obese diabetics.Br J Clin Pharmacol. 1977 Oct;4(5):529-33. doi: 10.1111/j.1365-2125.1977.tb00781.x. Br J Clin Pharmacol. 1977. PMID: 334212 Free PMC article. Clinical Trial.
-
Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.Drugs. 1975;10(4):241-323. doi: 10.2165/00003495-197510040-00001. Drugs. 1975. PMID: 765100 Review.
-
Anorectic drugs: use in general practice.Drugs. 1976;11(5):378-93. doi: 10.2165/00003495-197611050-00002. Drugs. 1976. PMID: 782835 Review.